Abstract 1100: Gain and loss of function genome-wide CRISPR screens identify Hippo signaling as an important driver of resistance in EGFR mutant lung cancer

MLA

Stacey Price, et al. “Abstract 1100: Gain and Loss of Function Genome-Wide CRISPR Screens Identify Hippo Signaling as an Important Driver of Resistance in EGFR Mutant Lung Cancer.” Cancer Research, vol. 81, July 2021, p. 1100. EBSCOhost, https://doi.org/10.1158/1538-7445.am2021-1100.

APA

Stacey Price, Erica Banks, Hannah Thorpe, James E. Brownell, Matthias Pfeifer, Paul Smith, Jonathan S. Brammeld, Ultan McDermott, Shanade Dunn, Nin Guan, Aurélie Bornot, Maria Luisa Guerriero, Matthew J. Martin, James Pilling, Daniel O’Neill, & Davide Gianni. (2021). Abstract 1100: Gain and loss of function genome-wide CRISPR screens identify Hippo signaling as an important driver of resistance in EGFR mutant lung cancer. Cancer Research, 81, 1100. https://doi.org/10.1158/1538-7445.am2021-1100

Chicago

Stacey Price, Erica Banks, Hannah Thorpe, James E. Brownell, Matthias Pfeifer, Paul Smith, Jonathan S. Brammeld, et al. 2021. “Abstract 1100: Gain and Loss of Function Genome-Wide CRISPR Screens Identify Hippo Signaling as an Important Driver of Resistance in EGFR Mutant Lung Cancer.” Cancer Research 81 (July): 1100. doi:10.1158/1538-7445.am2021-1100.